Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Kerwin · SciRah

Researcher profile · Semantic Scholar

E. Kerwin

Share profile

E. Kerwin — researcher profile on SciRah

h-index: 36
Works: 292
Citations: 6,703

Most-cited papers

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Laurie A. Lee, Z. Bailes, N. Barnes, L. Boulet +14 more
2020The Lancet Respiratory Medicine189 citations Open access
Semantic Scholar
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
F. Maltais, L. Bjermer, E. Kerwin, P. Jones +8 more
2019Respiratory Research118 citations Open access
Semantic Scholar
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
I. Leroux-Roels, Matthew G. Davis, K. Steenackers, B. Essink +18 more
2022Journal of Infectious Diseases111 citations Open access
Semantic Scholar
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
A. Lazaar, B. Miller, A. Donald, T. Keeley +62 more
2020Respiratory Research67 citations Open access
Semantic Scholar
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
P. Korenblat, E. Kerwin, I. Leshchenko, K. Yen +7 more
2018Respiratory Medicine50 citations Open access
Semantic Scholar
Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
D. Tashkin, A. Amin, E. Kerwin
2020International Journal of COPD40 citations Open access
Semantic Scholar
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
R. Panettieri, T. Welte, K. Shenoy, S. Korn +6 more
2020Journal of Asthma and Allergy37 citations Open access
Semantic Scholar
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
G. Ferguson, E. Kerwin, T. Rheault, T. Bengtsson +1 more
2021International Journal of COPD36 citations Open access
Semantic Scholar
Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease.
J. Donohue, E. Kerwin, S. Sethi, B. Haumann +5 more
2019Respiratory Medicine35 citations Open access
Semantic Scholar
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial
R. Pajon, Y. Paila, B. Girard, G. Dixon +16 more
2021Nature Medicine34 citations Open access
Semantic Scholar
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
S. Sethi, E. Kerwin, H. Watz, G. Ferguson +5 more
2019International Journal of COPD33 citations Open access
Semantic Scholar
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study
E. Kerwin, G. Ferguson, Mindy Mo, Kiernan DeAngelis +1 more
2019Respiratory Research29 citations Open access
Semantic Scholar
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
S. Andreas, M. Testa, L. Boyer, G. Brusselle +16 more
2022The Lancet Respiratory Medicine28 citations Open access
Semantic Scholar
Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)
M. Castro, E. Kerwin, David S Miller, A. Pedinoff +7 more
2021EClinicalMedicine28 citations Open access
Semantic Scholar
Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective
Dave Singh, A. D'Urzo, J. Donohue, E. Kerwin
2019Respiratory Research26 citations Open access
Semantic Scholar
Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
E. Kerwin, L. Hickey, C. Small
2019Respiratory Medicine20 citations Open access
Semantic Scholar
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
Dave Singh, A. D'Urzo, J. Donohue, E. Kerwin +4 more
2019International Journal of COPD19 citations Open access
Semantic Scholar
Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza
Grace Roberts, Shuguang Chen, P. Yates, A. Madan +6 more
2019Open Forum Infectious Diseases17 citations Open access
Semantic Scholar
Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
E. Kerwin, A. Wachtel, L. Sher, J. Nyberg +5 more
2018Respiratory Medicine16 citations Open access
Semantic Scholar
Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma
D. Ng, E. Kerwin, M. White, S. Miller +3 more
2020Journal of Aerosol Medicine15 citations Open access
Semantic Scholar
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
J. Donohue, E. Kerwin, S. Sethi, B. Haumann +5 more
2019Respiratory Research14 citations Open access
Semantic Scholar
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids
E. Kerwin, S. Pascoe, Z. Bailes, R. Nathan +6 more
2020Respiratory Research13 citations Open access
Semantic Scholar
Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
L. Dunn, E. Kerwin, Kiernan DeAngelis, P. Darken +2 more
2019Pulmonary Pharmacology & Therapeutics11 citations Open access
Semantic Scholar
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
E. Kerwin, R. Tosiello, Barry Price, S. Sanjar +1 more
2018International Journal of COPD10 citations Open access
Semantic Scholar
ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
E. Kerwin, A. Preece, Dimitra Brintziki, K. Collison +1 more
2019Journal of Allergy and Clinical Immunology: In Practice9 citations Open access
Semantic Scholar
Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study
E. Kerwin, J. Donohue, G. Ferguson, V. Ganapathy +2 more
2019Journal of Aerosol Medicine9 citations Open access
Semantic Scholar
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
C. Vogelmeier, I. Naya, F. Maltais, L. Bjermer +6 more
2021International Journal of COPD8 citations Open access
Semantic Scholar
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial
L. Bjermer, I. Boucot, C. Vogelmeier, F. Maltais +5 more
2021Advances in Therapy8 citations Open access
Semantic Scholar
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
L. Bjermer, I. Boucot, F. Maltais, E. Kerwin +6 more
2021International Journal of COPD8 citations Open access
Semantic Scholar
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
C. Vogelmeier, E. Kerwin, L. Bjermer, L. Tombs +7 more
2020Therapeutic Advances in Respiratory Disease8 citations Open access
Semantic Scholar
Comparative Efficacy and Safety of Umeclidinium/Vilanterol, Umeclidinium and Salmeterol in Symptomatic Maintenance-Naïve and Maintenance-Treated Chronic Obstructive Pulmonary Disease: A Pre-Specified Secondary Analysis of the EMAX Trial
L. Bjermer, E. Kerwin, F. Maltais, P. Jones +7 more
2019B45. COPD: TREATMENT8 citations
Semantic Scholar
Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies
E. Kerwin, L. Murray, X. Niu, C. Dembek
2020International Journal of COPD7 citations Open access
Semantic Scholar
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
A. D'Urzo, Dave Singh, J. Donohue, E. Kerwin +5 more
2019International Journal of COPD7 citations Open access
Semantic Scholar
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
Courtney Crim, M. Watkins, E. Bateman, G. Feldman +7 more
2019International Journal of COPD7 citations Open access
Semantic Scholar
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial
C. Vogelmeier, P. Jones, E. Kerwin, I. Boucot +5 more
2021Respiratory Research6 citations Open access
Semantic Scholar
ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.
E. Kerwin, S. Spangenthal, M. Zvarich, Valerie Millar +3 more
2020Chronic obstructive pulmonary diseases6 citations Open access
Semantic Scholar
Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER)
E. Kerwin, G. Feldman, J. Pearle, Luis de la Cruz +3 more
2021COPD5 citations Open access
Semantic Scholar
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
E. Kerwin, I. Boucot, C. Vogelmeier, F. Maltais +6 more
2020Therapeutic Advances in Respiratory Disease5 citations Open access
Semantic Scholar
Health-Related Quality of Life Improvements in Moderate to Very Severe Chronic Obstructive Pulmonary Disease Patients on Nebulized Glycopyrrolate: Evidence from the GOLDEN Studies.
G. Ferguson, E. Kerwin, J. Donohue, V. Ganapathy +3 more
2018Chronic obstructive pulmonary diseases5 citations Open access
Semantic Scholar
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment
E. Kerwin, P. Dorinsky, Mehul Patel, K. Rossman +5 more
2021Journal of Asthma4 citations Open access
Semantic Scholar
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis
J. Donohue, E. Kerwin, C. Barnes, Edmund J. Moran +2 more
2020BMC Pulmonary Medicine4 citations Open access
Semantic Scholar
Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow® CS
J. Stephenson, C. Dembek, Amanda Caldwell-Tarr, R. Conto +2 more
2020International Journal of COPD4 citations Open access
Semantic Scholar
Bone Mineral Density and Ocular Safety After 52 Weeks' Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Using Co-Suspension Delivery Technology in COPD
E. Kerwin, G. Ferguson, Mindy Mo, Kiernan DeAngelis +1 more
2019B45. COPD: TREATMENT4 citations
Semantic Scholar
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
C. Cappelletti, A. Maes, K. Rossman, M. Gillen +3 more
2021Clinical drug investigation3 citations Open access
Semantic Scholar
121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic
J. R. Guiñazú, J. Tica, C. Andrews, Matthew G. Davis +11 more
2020Open Forum Infectious Diseases3 citations Open access
Semantic Scholar
119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated
J. Tica, J. R. Guiñazú, C. Andrews, Matthew G. Davis +11 more
2020Open Forum Infectious Diseases3 citations Open access
Semantic Scholar
Pharmacokinetic Study of Epinephrine Hydrofluoroalkane (Primatene MIST) Metered-Dose Inhaler
E. Kerwin, Tony Marrs, M. Z. Luo, J. Zhang
2020Journal of Aerosol Medicine3 citations Open access
Semantic Scholar
EFFICACY OF REVEFENACIN, A LONG-ACTING MUSCARINIC ANTAGONIST FOR NEBULIZED THERAPY, IN COPD PATIENTS WITH MARKERS OF MORE SEVERE DISEASE
J. Donohue, E. Kerwin, C. Barnes, Edmund J. Moran +3 more
2018Chest3 citations
Semantic Scholar
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD
E. Kerwin, S. Spangenthal, C. Kollar, E. St Rose +1 more
2018Respiratory Research3 citations Open access
Semantic Scholar
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
S. Shukla, D. Shah, Alan A. Martin, N. Risebrough +11 more
2021International Journal of COPD2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Maltais×11
Invite
F. Maltais — researcher profile on SciRah
L. Bjermer×9
Invite
L. Bjermer — researcher profile on SciRah
L. Tombs×9
Invite
L. Tombs — researcher profile on SciRah
I. Boucot×9
Invite
I. Boucot — researcher profile on SciRah

×9

Invite

C. Vogelmeier — researcher profile on SciRah

Invite

J. Donohue — researcher profile on SciRah

Invite

P. Jones — researcher profile on SciRah

Invite

D. Lipson — researcher profile on SciRah

Invite

C. Compton — researcher profile on SciRah

Invite

I. Naya — researcher profile on SciRah

Invite

G. Ferguson — researcher profile on SciRah

Invite

P. Dorinsky — researcher profile on SciRah